Product Program year 2025 Source: CMS Open Payments

Donidalorsen

Drug Pulmonology & Immunology

Open in the dashboard

General payments

$29,603

80 payments

Research payments

$1,020

1 payment

Through program year 2025, $29,603 in general payments and $1,020 in research payments were reported against Donidalorsen (Pulmonology & Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $29,603 80
2025 Research $1,020 1

Breakdown

Who paid General payments · program year 2025
  1. Ionis Pharmaceuticals, Inc. $29,603 80 payments
Top recipients General payments · program year 2025
  1. Marc Riedl Allergy & Immunology · San Diego, CA $8,340 28% · 2 payments
  2. Timothy Craig Allergy & Immunology · Hershey, PA $2,859 10% · 2 payments
  3. H James Wedner Allergy & Immunology · Saint Louis, MO $2,840 10% · 1 payment
  4. William Lumry Dallas, TX $2,840 10% · 1 payment
  5. Theodore Kelbel Allergy & Immunology · Grand Rapids, MI $2,780 9% · 1 payment

The top 5 of 76 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Allergy & Immunology $19,812 74% · 30 practitioners
  2. Allergy & Immunology Internal Medicine $5,678 21% · 5 practitioners
  3. Physician Assistant $412 2% · 13 practitioners
  4. Allergy Allergy & Immunology $306 1% · 10 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $229 <1% · 6 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $8,711 29% · 4 recipients
  2. Texas $3,138 11% · 11 recipients
  3. Pennsylvania $3,004 10% · 8 recipients
  4. Missouri $2,951 10% · 5 recipients
  5. New York $2,885 10% · 2 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

80 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record